Google Finance Alerts For CERU, INNL

and CBR
Biotech and pharma companies are always trying to outperform their rivals with new
research and great financial numbers. For penny stock investors, pharma and biotech
companies are gold mines promising exquisite returns, great turnaround capabilities
and even better return percentages. The beauty of penny stocking is finding stocks with
a great turnaround capacity. These stocks can turn hundreds into thousands and
thousands into millions within days. An investor only needs to ensure that he is finding
a stock he can bank upon. Here are your Google finance alerts for 3 of the hottest
pharma and biotech stocks.

CERU
Cerulean Pharma stocks are making investors happy with great returns. Per our Google
finance alerts, the stock is trading at $3.32, up by 7.79 percent after opening the trading
day at $3. The company is trading in lower volumes today but it is slowly moving
towards its 52-week high of $4.33. The 52-week low for the stock is $0.63, which
represents the tremendous growth that this stock has experienced in the past 1 year. The
stock has a consensus buy rating, making it one of the top penny stocks pick for the
month. The consensus price target of the stock is $5.50, higher than its 52-week high.
The stock has performed 368.79% and there is great growth option available in this
company.

Cerulean Pharma is known for its Dynamic Tumor Targeting platform which helped in
cancer treatment with the help of Nano-technology. This platform helps in avoiding the
exposure of healthy cells to cancer treatments while implementing a higher dose of
concentrated drug to the cancerous tumor cells. Analysts are optimistic about the stock
as the company announced that it is looking for business combination, merger, or sale of
the company or a strategic investment into the company. They are also considering
disposition or sale or licensing of the companys assets. While the company merely
suggested that it is investigating the availability of such a resource, analysts believe that
they have already found one, which is leading to the investors buying the stock and
raising the stock price.

INNL
Innocoll Holdings plc opened at $1.58 today and the stock has gone town by 33.16
percent since then to $1.25. The share trade volume is extremely low today. The firm,
which has a market cap of $37.19 million and EPS of $-6.01 has a high degree of
volatility showing a high risk high portfolio. The 52-week lowest of the firm is $0.53
while the 52-week highest is $12.94, showing the ability of Innocoll Holdings to make
hundreds out of millions and vice versa very quickly. Check out Google finance alerts for
more details.
This global firm is involved in making specialty pharmaceuticals and covers many
programs in their late stage development. It manufactures various devices too. Innocoll
is known for its proprietary platform based on collagen-based fully biodegradable and
bio restorable technology. The firms financial reports were for the year ending
December 2016 were revealed recently in which they announced the successful
expansion of a manufacturing facility in Saal, Germany. They also attended a Type A
meeting with the FDA, discussing their plans for the future.

The company reported a loss of $0.13 per share in Q4 2016, a year-over-year decrease of
$0.20. However, revenues also lowered during Q4 as the company generated only $0.6
million against $0.9 million during Q4 2015. Analysts are keeping a close look on the
stocks performance as it is being poorly traded today. Check our Google finance alerts
to know more about the impact of this report on the companys stocks.

The development pipeline of the company was under stress in the past 1 year.
COGENZIA and XARACOLL failed to perform well during the year which put further
stress on the valuation of the companys stock. The company could have an offer for an
entire issued capital buyout which could prove to be beneficial for the shareholders.
However, unless that happens, XARACOLL could prove to be a pivot point and a savior
for the company.

CBR
The stocks of Ciber Inc. are hovering over their 52-week lowest of $0.22. Currently
trading at $0.470, the stock witnessed a 5.47 percent decline after opening at $0.49
today. The 52-week highest of the stock is $2.36, which seems a farfetched number as of
now. According to our Google finance alerts the companys stock is trading at a
negligible volume today. The share has buy ratings and analysts are expecting that
despite a short-term problem, the shares could easily reach $1 per share soon as the
stock has a bullish indicator as of now. Investors will have to patiently wait and watch
for the analysts estimates to bear fruits.

The share is expected to grow by 100% but only in the next 52-weeks. It has been going
down since hitting a peak last year but the last one month has presented a good outcome
for the investors. For the stock to improve and reach $1, it could take another few weeks
but the analysts are certain that this could be achieved as there is still some room for
improvement in the stock. Other numbers for the company are not very exciting per our
Google finance alerts. The Return on Assets is -40.52 percent and Return on Equity is
-69.69 percent. The industry standard ROA is 11.8 percent while the ROE is 17.57%.

These pharma stocks still have room to grow. This industry works on a high-risk and
high-reward basis because of which you can count upon the stocks ability to grow with
time. To stay updated with the latest news and analysis about penny stocks, subscribe to
our Google finance alerts. If you dont keep a track of your investments, a penny stock
can easily make you lose all your money. We know that penny stocking is a losing game
without the right information and this is why we give you only the best and most
authentic stock information.